Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-24 @ 11:10 PM
NCT ID:
NCT02458469
Eligibility Criteria:
Inclusion Criteria:
* Adults with SCI (\>6months after spinal cord injury) at the T6 level/above
Exclusion Criteria:
* Pregnant and lactating females
* Heart failure, vascular disease, or stroke
* Advanced chronic obstructive pulmonary disease (COPD), liver disease, and chronic kidney disease
* BMI \>38 kg/m2
* Mechanical ventilation dependence
* The following medications are not allowed (potential interaction with buspirone or inhibition of the CYP3A4 system):
* cimetidine
* ketoconazole
* ritonavir
* itraconazole
* erythromycin
* diltiazem
* verapamil
* Monoamine oxidase (MAO) inhibitors \[such as Marplan, Nardil, Parmate, Emsam\]
* Other prohibited concomitant medications include haloperidol, trazodone, or triazolam
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02458469
Study Brief:
Protocol Section:
NCT02458469